Jan P. Dumanski mainly investigates Genetics, Molecular biology, Genome, Genetic variation and Phenotype. Chromosome 22, Medical genetics, Genomics, Locus and Gene are subfields of Genetics in which his conducts study. He has included themes like Dermatofibrosarcoma protuberans, PDGFB Gene, Laminin, PDGFB and Chromosome in his Molecular biology study.
His work on Human genome as part of general Genome research is often related to Human blood, thus linking different fields of science. His studies deal with areas such as Segmental duplication, Germline, Genetic heterogeneity, Single-nucleotide polymorphism and Human genetics as well as Genetic variation. His Phenotype research incorporates elements of Genetic variability, Genotype and Concordance.
The scientist’s investigation covers issues in Genetics, Gene, Chromosome 22, Chromosome and Molecular biology. His works in Locus, Comparative genomic hybridization, Gene mapping, Copy-number variation and Human genome are all subjects of inquiry into Genetics. His research on Gene often connects related topics like Neurofibromatosis type 2.
While the research belongs to areas of Chromosome 22, he spends his time largely on the problem of Chromosome 21, intersecting his research to questions surrounding Chromosome 15. His study in Chromosome is interdisciplinary in nature, drawing from both Cancer, Mutation, Immune system, Genetic marker and Y chromosome. His Cancer research includes themes of Medical genetics, Immunology and Pathology.
Jan P. Dumanski mainly focuses on Genetics, Chromosome, Y chromosome, Cancer and Medical genetics. His study connects Increased risk and Genetics. His Chromosome research incorporates themes from Odds ratio, Incidence, Peripheral blood and Risk factor.
His Y chromosome study deals with Genetic predisposition intersecting with Biobank, Genome-wide association study and Genetic marker. His research in Cancer intersects with topics in Cancer research and Immunology. His Medical genetics research is multidisciplinary, relying on both Alzheimer's disease, Life expectancy, Genetic variation and Genetic testing.
His scientific interests lie mostly in Chromosome, Medical genetics, Genetics, Cancer and Immunology. Jan P. Dumanski combines subjects such as Odds ratio, Longitudinal study, Incidence, Epidemiology and Cohort study with his study of Chromosome. His Medical genetics research is multidisciplinary, incorporating perspectives in Genome, Human genome, Genomics, Phenotype and Mutation.
His Genetic variation and Genetic testing investigations are all subjects of Genetics research. His work deals with themes such as Genome-wide association study and Genetic marker, Y chromosome, Gene, Genetic predisposition, which intersect with Cancer. Jan P. Dumanski has included themes like Polymorphism, Case-control study, Life expectancy, Alzheimer's disease and Prospective cohort study in his Immunology study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
Guy A. Rouleau;Philippe Merel;Mohini Lutchman;Marc Sanson;Marc Sanson.
The DNA sequence of human chromosome 22
I. Dunham;N. Shimizu;B. A. Roe;S. Chissoe.
Phenotypically Concordant and Discordant Monozygotic Twins Display Different DNA Copy-Number-Variation Profiles
Carl E.G. Bruder;Arkadiusz Piotrowski;Antoinet A.C.J. Gijsbers;Robin Andersson.
American Journal of Human Genetics (2008)
Clonal Genomic Alterations in Glioma Malignancy Stages
James Cd;Carlbom E;Dumanski Jp;Hansen M.
Cancer Research (1988)
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma
Marie Pierre Simon;Florence Pedeutour;Nicolas Sirvent;Josiane Grosgeorge.
Nature Genetics (1997)
The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
A Shimizu;K P O'Brien;T Sjöblom;K Pietras.
Cancer Research (1999)
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Tobias Sjöblom;Akira Shimizu;Kevin P. O’Brien;Kristian Pietras.
Cancer Research (2001)
LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies
Rita Barresi;Daniel E Michele;Motoi Kanagawa;Hollie A Harper.
Nature Medicine (2004)
Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
Lars A Forsberg;Chiara Rasi;Niklas Malmqvist;Hanna Davies.
Nature Genetics (2014)
Molecular Recognition by LARGE Is Essential for Expression of Functional Dystroglycan
Motoi Kanagawa;Fumiaki Saito;Stefan Kunz;Takako Yoshida-Moriguchi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: